JW Lifescience Corporation (KRX: 234080)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,390
+200 (1.79%)
Nov 15, 2024, 3:30 PM KST

JW Lifescience Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
26,60928,14414,96112,91417,30021,938
Upgrade
Depreciation & Amortization
15,67415,53114,95613,24512,24611,626
Upgrade
Loss (Gain) From Sale of Assets
199.67205.8195.87362.944.14-18.96
Upgrade
Asset Writedown & Restructuring Costs
----8546.75-
Upgrade
Loss (Gain) From Sale of Investments
-43.5----
Upgrade
Loss (Gain) on Equity Investments
-3,218-6,5324,9214,7807,129-0.14
Upgrade
Other Operating Activities
2,0261,3991,5752,60711,6223,855
Upgrade
Change in Accounts Receivable
-19,017-2,079-21,1032,576-828.49-3,803
Upgrade
Change in Inventory
-1,558-1,285-1,057-4,517-999.73-1,145
Upgrade
Change in Accounts Payable
7,1183,5402,7301,781-554.22-340.88
Upgrade
Change in Other Net Operating Assets
-2,878-1,392-2,950-3,498788.97-7,836
Upgrade
Operating Cash Flow
24,95737,57414,12930,16546,75524,276
Upgrade
Operating Cash Flow Growth
-19.25%165.94%-53.16%-35.48%92.60%-32.81%
Upgrade
Capital Expenditures
-8,528-8,153-8,079-18,976-15,931-8,092
Upgrade
Sale of Property, Plant & Equipment
8.63.721.719.4938.18
Upgrade
Sale (Purchase) of Intangibles
-117.48-113.8-214.05-259.87-307.25-264.01
Upgrade
Investment in Securities
1,51617,036-24,755-655.91-19,700-10
Upgrade
Other Investing Activities
510.44-736.19-0.26184.9767.62-43.15
Upgrade
Investing Cash Flow
-8,7108,037-28,247-22,805-37,561-8,371
Upgrade
Short-Term Debt Issued
-43,500139,700157,80088,700102,420
Upgrade
Long-Term Debt Issued
--44,185770--
Upgrade
Total Debt Issued
61,50043,500183,885158,57088,700102,420
Upgrade
Short-Term Debt Repaid
--49,500-162,350-145,450-90,740-107,980
Upgrade
Long-Term Debt Repaid
--15,566-677.41-3,483-6,505-5,342
Upgrade
Total Debt Repaid
-67,989-65,066-163,027-148,933-97,245-113,322
Upgrade
Net Debt Issued (Repaid)
-6,489-21,56620,8579,637-8,545-10,902
Upgrade
Repurchase of Common Stock
----6,749--
Upgrade
Dividends Paid
-7,742-7,742-7,742-7,917-7,917-7,917
Upgrade
Other Financing Activities
---0---
Upgrade
Financing Cash Flow
-14,231-29,30813,115-5,029-16,463-18,820
Upgrade
Miscellaneous Cash Flow Adjustments
0---0--0
Upgrade
Net Cash Flow
2,01616,302-1,0032,331-7,269-2,915
Upgrade
Free Cash Flow
16,42929,4216,04911,18930,82416,183
Upgrade
Free Cash Flow Growth
-28.75%386.35%-45.93%-63.70%90.47%-37.97%
Upgrade
Free Cash Flow Margin
7.66%14.22%3.20%6.59%16.80%9.51%
Upgrade
Free Cash Flow Per Share
1060.971900.03390.67718.141946.621022.02
Upgrade
Cash Interest Paid
2,2402,8692,9491,2531,2951,876
Upgrade
Cash Income Tax Paid
5,3366,4336,0449,5374,7784,576
Upgrade
Levered Free Cash Flow
8,88226,7848,71710,27321,79815,043
Upgrade
Unlevered Free Cash Flow
10,31028,46710,64911,07323,42916,122
Upgrade
Change in Net Working Capital
16,217-1,91512,944695.63-2,7645,742
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.